Charles Flagg, who is stricken with Alzheimer’s disease, sits for an infusion while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer’s disease, the most common form of dementia. (AP Photo/Charles Krupa)
A company that claims to have the first drug to slow mental decline from Alzheimer’s disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval.
Excitement and skepticism have surrounded aducanumab since its developers stopped two studies…
На данный момент можно найти площадку с играми, где есть карточные и настольные игры, новейших и топовых автоматов, мгновенных игр и лайв-игр с live-дилерами....
